0
0
32 words
0
Comments
The agency previously argued the merger could harm patients who are prescribed Horizon’s two fastest-growing drugs.
You are the first to view
https://www.forbes.com/sites/tylerroush/2023/09/01/amgens-278-billion-purchase-of-horizon-therapeutics-on-after-ftc-settlement/
Create an account
or login to join the discussion